ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

MDNA Medicenna Therapeutics Corporation

0.157
0.00 (0.00%)
プレマーケット
最終更新日: 09:00:00
15分遅延
名称 銘柄コード 市場 種別
Medicenna Therapeutics Corporation MDNA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 0.157 09:00:00
始値 安値 高値 終値 前日終値
0.157
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0104:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/4/2704:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/4/2603:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/4/2305:40EDGAR2Form AW - Amendment Withdrawal Request
2024/4/1706:05EDGAR2Form S-8 POS - Securities to be offered to employees in..
2024/4/1706:05EDGAR2Form F-3/A - Registration statement by foreign private..
2024/4/1706:04EDGAR2Form F-10POS - Post-effective amendment to a F-10EF..
2024/4/1003:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/4/0503:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/1421:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/2506:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/1000:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0523:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2304:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0922:56GLOBEMedicenna to Present 4 Year Follow-up Phase 2b Bizaxofusp..
2023/11/0900:29EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/11/0621:00GLOBEMedicenna Announces Promising Single-Agent Response and..
2023/11/0401:00GLOBEMedicenna Presents Preclinical Data on MDNA113, its Targeted..
2023/10/2720:55GLOBEMedicenna Announces Nasdaq Delisting and Cutback of..
2023/10/2604:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2520:00GLOBEMedicenna Therapeutics Doses First Patient in Phase 2..
2023/10/2420:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/2420:15GLOBEMedicenna Announces Presentations at the 38th Annual Meeting..
2023/10/1021:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/1020:07GLOBEMedicenna Therapeutics Appoints Humphrey Gardner, M.D., as..
2023/10/0406:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/10/0320:00GLOBEMedicenna Presents Preclinical MDNA223 BiSKIT Data at the..
2023/9/2906:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/2906:00GLOBEMedicenna Announces Results of Annual and Special Meeting of..
2023/9/2823:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/2820:00GLOBEMedicenna to Present at the AACR Special Conference Cancer..
2023/9/0620:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/9/0620:00GLOBEMedicenna to Participate at The H.C. Wainwright 25th Annual..
2023/8/2905:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/2905:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/2820:00GLOBEMedicenna Announces the Appointment of Jeff Caravella as..
2023/8/1505:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/1420:00GLOBEMedicenna Establishes Boston Presence, Appoints Brent..
2023/8/1006:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/0822:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/0820:00GLOBEMedicenna Appoints Dr. Arash Yavari as Chair of Development..
2023/8/0421:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/0420:00GLOBEMedicenna Therapeutics to Provide Clinical Update from Phase..
2023/8/0201:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/8/0122:30GLOBEMedicenna Strengthens IP Portfolio with U.S. Patent Granted..
2023/7/2821:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/2820:00GLOBEMedicenna Reports First Quarter Fiscal 2024 Financial..
2023/7/2521:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/7/2520:00GLOBEMedicenna Presents at National Brain Tumor Society's..
2023/7/0623:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

最近閲覧した銘柄

Delayed Upgrade Clock